Security key
221015100
Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)
CUSIP: 221015100
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 91,091,040
- Total 13F shares
- 19,183,314
- Share change
- -3,020
- Total reported value
- $33,762,501
- Put/Call ratio
- 361%
- Price per share
- $1.76
- Number of holders
- 46
- Value change
- +$90,871
- Number of buys
- 15
- Number of sells
- 18
Report period
Q4 2023
Institutions
46
Top holders
10
CRVS full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Corvus Pharmaceuticals, Inc. SEC filings
Corvus Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 221015100
Recent filing periods:
Top shareholders of CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
7.6%
|
6,943,654
|
$10,137,735 | — | 30 Sep 2023 | |
| ADAMS STREET PARTNERS LLC |
13F
3/4/5
|
Company · 10%+ Owner |
3.6%
|
3,275,616
|
$4,782,399 | — | 30 Sep 2023 | |
| SAMLYN CAPITAL, LLC |
13F
|
Company |
2.6%
|
2,405,764
|
$3,512,415 | — | 30 Sep 2023 | |
| BVF INC/IL |
13F
|
Company |
1.5%
|
1,370,947
|
$2,001,583 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.5%
|
1,346,932
|
$1,966,521 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.57%
|
521,251
|
$761,027 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.46%
|
421,743
|
$616,000 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.4%
|
360,380
|
$526,283 | — | 30 Sep 2023 | |
| TOWERVIEW LLC |
13F
|
Company |
0.38%
|
342,478
|
$500,018 | — | 30 Sep 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.3%
|
273,007
|
$398,590 | — | 30 Sep 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.27%
|
248,900
|
$363,394 | — | 30 Sep 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.22%
|
198,220
|
$289,401 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.21%
|
192,506
|
$281,059 | — | 30 Sep 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
149,300
|
$217,978 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.15%
|
138,403
|
$202,068 | — | 30 Sep 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.14%
|
127,968
|
$186,833 | — | 30 Sep 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.12%
|
108,024
|
$157,715 | — | 30 Sep 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.08%
|
70,883
|
$103,489 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.08%
|
69,907
|
$102,064 | — | 30 Sep 2023 | |
| MYDA Advisors LLC |
13F
|
Company |
0.08%
|
68,814
|
$100,468 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
65,017
|
$94,925 | — | 30 Sep 2023 | |
| JACKSON SQUARE CAPITAL, LLC |
13F
|
Company |
0.07%
|
63,773
|
$93,109 | — | 30 Sep 2023 | |
| Hikari Power Ltd |
13F
|
Company |
0.05%
|
49,959
|
$73,000 | — | 30 Sep 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.05%
|
49,324
|
$72,013 | — | 30 Sep 2023 | |
| EcoR1 Capital, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
81,077
|
$64,051 | — | 30 Sep 2021 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.04%
|
39,493
|
$57,000 | — | 30 Sep 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.03%
|
27,099
|
$39,565 | — | 30 Sep 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.03%
|
24,737
|
$36,116 | — | 30 Sep 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.02%
|
21,219
|
$30,980 | — | 30 Sep 2023 | |
| COMMERCE BANK |
13F
|
Company |
0.02%
|
20,000
|
$29,200 | — | 30 Sep 2023 | |
| XTX Topco Ltd |
13F
|
Company |
0.02%
|
19,244
|
$28,096 | — | 30 Sep 2023 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.02%
|
18,754
|
$27,381 | — | 30 Sep 2023 | |
| Virtu Financial LLC |
13F
|
Company |
0.02%
|
17,366
|
$25,000 | — | 30 Sep 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.02%
|
15,668
|
$22,875 | — | 30 Sep 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.02%
|
15,617
|
$22,801 | — | 30 Sep 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
14,890
|
$21,739 | — | 30 Sep 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
13,682
|
$19,975 | — | 30 Sep 2023 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.01%
|
13,050
|
$19,000 | — | 30 Sep 2023 | |
| AVITY INVESTMENT MANAGEMENT INC. |
13F
|
Company |
0.01%
|
11,480
|
$16,761 | — | 30 Sep 2023 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.01%
|
11,232
|
$16,399 | — | 30 Sep 2023 | |
| WHITTIER TRUST CO OF NEVADA INC |
13F
|
Company |
0.01%
|
11,200
|
$16,352 | — | 30 Sep 2023 | |
| Masso Torrence Wealth Management Inc. |
13F
|
Company |
0.01%
|
10,000
|
$14,600 | — | 30 Sep 2023 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
6,700
|
$9,782 | — | 30 Sep 2023 | |
| Northwest Capital Management Inc |
13F
|
Company |
0%
|
3,397
|
$4,960 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
3,172
|
$4,631 | — | 30 Sep 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
2,400
|
$3,504 | — | 30 Sep 2023 | |
| FMR LLC |
13F
|
Company |
0%
|
1,101
|
$1,607 | — | 30 Sep 2023 | |
| NATIXIS |
13F
|
Company |
0%
|
800
|
$1,168 | — | 30 Sep 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
791
|
$1,154 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
247
|
$361 | — | 30 Sep 2023 |
Institutional Holders of Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) as of Q4 2023
As of 31 Dec 2023,
Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,183,314 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, ADAMS STREET PARTNERS LLC, SAMLYN CAPITAL, LLC, BVF INC/IL, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., TOWERVIEW LLC, GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY.
This page lists
47
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
52
Q4 2023 holders
46
Holder diff
-6
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.